Home > Research Institute > Available Trials > A Phase 1 Study of SEA-TGT (SGN-TGT) in Subjects with Advanced Malignancies
A Phase 1 Study of SEA-TGT (SGN-TGT) in Subjects with Advanced Malignancies
A Phase 1 Study of SEA-TGT (SGN-TGT) in Subjects with Advanced Malignancies (SGNTGT-001)
Disease Types: Lung, Melanoma
Available at: Roanoke
A Phase 1 Study of SEA-TGT (SGN-TGT) in Subjects with Advanced Malignancies (SGNTGT-001)
For More Information: